Clinical TrialsSearch results
Number of results: 761
Other
- Phase I/II trial of chemoradiotherapy concurrent with S-1 and cisplatin in patients with clinical stage II/III esophageal carcinoma (JCOG0604)
- esophageal neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2007-05-08
Other
- Phase I/II study on combination therapy consisting of a fixed dose-rate infusion of gemcitabine with oral fluorinated pyrimidine compound S-1 (FGS) in patients with gemcitabine-refractory advanced pancreatic cancer
- Patients with gemcitabine-refractory metastatic pancreatic cancer
- National Cancer Center Hospital, Hepatobiliary and Pancreatic Oncology Division
- 2006-07-20
Recruiting
- Phase I/II Study of the Selective RET Inhibitor TAS0953/HM06 in Patients with Advanced Solid Tumors with RET gene abnormalities
- Solid tumor (Non-small cell lung cancer, and so on)
- Masuda Noriyuki
- 2020-11-23
Other
- Phase I/II study of docetaxel, CDDP and 5-FU therapy in patients with unresectable or recurrent esophageal cancer (JCOG 0807)
- esophageal neoplasm
- Japan Clinical Oncology Group (JCOG)
- 2009-02-27
Other
- Phase I/II Study of Docetaxel and S-1 Combination Therapy for Advanced Non-small Cell Lung Cancer
- Advanced Non-small Cell Lung Cancer
- The Tokyo Cooperative Oncology Group
- 2005-11-14
Other
- Phase I/II Study of Combination Therapy of Oral Fluorinated Pyrimidine Compound S-1 with Low-dose Cisplatin in Patients with Unresectable and/or Recurrent Advanced Gastric Cancer Step 2: low dose cisplatin given twice a week + S-1
- unresectable or recurrent gastric cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2005-11-14
Other
- Phase I/II clinical trial of NZ-C1909
- Degenerative lumbar diseases
- Okawa Atsushi
- 2022-12-14
Recruiting
- Phase I study of non-viral gene-modified CAR-T cell therapy for ewing sarcoma or malignant solid tumors with expression of EPHB4 receptor
- Ewing's sarcoma or solid tumors diagnosed as advanced relapsed with no standard treatment or refract
- Naito Yoichi
- 2023-08-18
Other
- Phase I Study of gemtuzumab ozogamicin in combination with cytarabinne and idarubicin as induction therapy for relapsed or refractory patients with acute myeloid leukemia.
- Acute Myeloid Leukemia
- Japan Adult Leukemia Study Group
- 2008-05-10
Other
- Phase I clinical study of Glypican-3 peptide vaccine in patients with advanced Hepatocellular carcinoma
- Hepatocellular carcinoma
- Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East
- 2008-09-26